NEWARK, Del. — The global Viral Clearance Market is expanding as pharmaceutical and biotechnology companies strengthen viral safety controls across biologics development and manufacturing. According to Future Market Insights (FMI), the market is projected to grow from USD 1.0 billion in 2026 to USD 4.8 billion by 2036, registering a 16.9% CAGR during the forecast period. Growth is being...